Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

crawled date : 2021 - 03 - 01    crawled time : 12:03    save search

Tecnoglass to Attend the Raymond James 42nd Annual Institutional Investors Conference
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
TGLS | $58.72 1.82% 0.19% 680K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 3.25% H: 0.39% C: -3.01%

glass
Astec Reports Fourth Quarter 2020 Results
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
ASTE | $42.41 -0.19% -0.09% 75K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 1.59% H: 6.91% C: 4.38%

results report
MannKind Corporation Announces Proposed Private Placement of Convertible Senior Notes
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
MNKD | $4.12 -0.72% -0.48% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: -8.06% H: 0.95% C: -23.62%


STRATA Skin Sciences Announces CEO Transition
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
SSKN | $0.5101 -3.1% -1.23% 35K twitter stocktwits trandingview |
Health Technology
| | O: 0.55% H: 3.26% C: -5.98%

ceo skin leo
Clene Nanomedicine Awarded Michael J. Fox Foundation Grant to Accelerate the Development of CNM-Au8 as a Treatment for Parkinson’s Disease
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
CLNN | $0.3314 -7.87% -9.63% 640K twitter stocktwits trandingview |
| | O: 2.41% H: 6.27% C: 3.27%

disease treatment cnm-au8 parkinson
Athenex Receives FDA Complete Response Letter for Oral Paclitaxel Plus Encequidar for the Treatment of Metastatic Breast Cancer
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
ATNX | $0.2031 -7.78% 1.9M twitter stocktwits trandingview |
Health Technology
| | O: -54.96% H: 12.84% C: 0.18%

treatment fda cancer breast cancer response metastatic breast cancer
Axsome Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
AXSM | $68.21 -1.36% -1.3% 430K twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 6.63% C: 2.85%

financial results results
Trevena, Inc. to Participate in March Virtual Investor Conferences
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
TRVN | $0.3814 -7.65% -6.72% 68K twitter stocktwits trandingview |
Health Technology
| | O: 2.56% H: 3.18% C: 1.82%

conference
Morphic Reports Positive Interim Results from Single Ascending Dose Phase 1 Clinical Trial of MORF-057
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
MORF | $29.51 2.97% 2.91% 640K twitter stocktwits trandingview |
Health Technology
| | O: 24.45% H: 106.67% C: 88.56%

phase 1 positive results trial phase 3 phase 2
Satsuma Pharmaceuticals Announces Updated STS101 Development Plan
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
STSA | $1.1 -0.9% -0.91% 0 twitter stocktwits trandingview |
Health Technology
| | O: 24.12% H: 2.64% C: -7.66%


Arvinas Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
ARVN | $34.72 -4.33% -4.58% 650K twitter stocktwits trandingview |
Health Technology
| | O: 0.31% H: 1.82% C: -1.58%

financial results results
BioXcel Therapeutics Appoints June Bray to Board of Directors
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
BTAI 4 | $2.75 -5.17% -6.23% 2.2K twitter stocktwits trandingview |
Health Technology
| | O: 2.82% H: 2.5% C: 1.07%

therapeutics
BrainsWay Ltd. Announces Closing of $45.2 Million Underwritten Public Offering of American Depositary Shares Including Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
BWAY | $5.27 2.33% 1.34% 34K twitter stocktwits trandingview |
Health Technology
| | O: 0.58% H: 4.88% C: 3.95%

offering
Annexon Advances Classical Complement Platform with Initiation of Global Phase 2 ARCHER Trial in Patients with Geographic Atrophy
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
ANNX P | $5.74 -4.01% -4.18% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 3.13% H: 7.26% C: -0.37%

phase 2 trial
Gainers vs Losers
45% 55%

Top 10 Gainers
DYNT | $0.3704 -5.27% 43.09% 5.5M twitter stocktwits trandingview |
Health Technology

BRTX | $1.32 -1.49% 20.71% 3.3M twitter stocktwits trandingview |
Professional, Scientific, and T...

PTN | $1.82 -5.21% 15.38% 290K twitter stocktwits trandingview |
Health Technology

VIAO | $0.308 -26.67% 12.01% 390K twitter stocktwits trandingview |
Electronic Technology

HNRA | $2.36 -9.58% 11.86% 220K twitter stocktwits trandingview |
n/a

HYLN 4 | $1.32 -7.04% 8.33% 800K twitter stocktwits trandingview |
Producer Manufacturing

UMAC | $1.85 -2.12% 8.11% 6.1K twitter stocktwits trandingview |

BQ | $0.2429 -6.07% 6.63% 99K twitter stocktwits trandingview |
Consumer Non-Durables

GORO F | $0.534 -0.6% 6.55% 630K twitter stocktwits trandingview |
Non-Energy Minerals

LBRT 4 | $22.1 -1.6% 6.29% 2.1M twitter stocktwits trandingview |
Industrial Services


Your saved searches
Save your searches and get alerts when important news are released.